• Skip to content
  • Skip to menu
Smart science to improve lives™
    • View basket Checkout
    • Sign in
    • Contact
      • Português
      • Español
      • 日本語
      • 中文
    Open search Basket 0 View basket
    • English
    • Português
    • Español
    • 日本語
    • 中文
    • About
      • About
      • Our Decarbonisation Journey
        • Our Decarbonisation Journey
        • PCF Data
      • Unlocking sustainable ingredients for vaccines
      • Our commitment and purpose
      • The race to beat COVID-19
      • Our markets
        • Our markets
        • Consumer Health
        • Human pharmaceuticals
        • Veterinary health
      • Quality
        • Quality
        • Leaders in regulatory excellence
        • Locations
        • EXCiPACT
    • Product finder
    • Drug delivery solutions
      • Drug delivery solutions
      • Research materials
      • Explore by technology platform
        • Explore by technology platform
        • Small Molecule Delivery
        • Protein Delivery
        • Nucleic Acid Delivery
        • Adjuvant Systems
      • Explore by market
        • Explore by market
        • Consumer Health
        • Human pharmaceuticals
        • Veterinary Health
      • Explore new products
      • Explore by product
        • Explore by product
        • Adjuvants
        • Bioprocessing solutions
        • Controlled release drug delivery systems
        • Emollients and skin hydration
        • Film forming polymers
        • Lipid-based drug delivery technology
        • Natural phospholipids
        • Omega 3 APIs
        • Penetration enhancers
        • Pharmaceutical excipients
        • Pharmaceutical solvents
        • SEDDS and SMEDDS
        • Skin barrier repair
        • Super Refined™
    • Resources
      • Resources
      • Adjuvant GMP certificates
      • Pharmaceutical solubility guide
      • Webinars
      • Events
    • News and blog
    • Consumer Health
      • Consumer Health
      • Excipients for CBD
      • Nutritional supplements
      • Oral formulations
      • Oral hygiene
      • OTC
      • Transdermal drug delivery
    • Sign in
    • Contact
    1. Home
    2. Product finder
    3. Super Refined™ Oleyl Oleate

    Super Refined™ Oleyl Oleate

    Highly purified grade of pharmaceutical oleyl oleate. A plant-derived light and non-greasy emollient.  

    Chemical description

    Oleyl Oleate

    Whats next?

    Add to favourites

    View resources

    • Related resources
    • Material Safety Data Sheets

    Product details

    Pharmacopoeia compliance

    • JP/JPE
    • USP/NF

    Chemical group

    • Emollients

    Administration route

    • Topical

    Market application

    • Dermatology
    • Human pharmaceutical

    Functions

    • Emollient

    Physical form

    • Colourless to pale yellow liquid

    FREQUENTLY ASKED QUESTIONS

    Explore frequently asked questions about our Super Refined offering

    Drug stability can be compromised by oxidative impurities and reactive species. Our Super Refined™ excipients undergo Croda Pharma's proprietary purification process that reduces these impurities, significantly improving formulation stability and extending shelf life.  

    By employing our proprietary purification technology to reduce aldehydes, peroxides, and other impurities, Super Refined™ excipients greatly reduce the potential for cellular irritation and adverse reactions.

    Super Refined™ excipients are ideal for all administration routes: injectable, ophthalmic, nasal, pulmonary, auricular, oral, topical, transdermal, vaginal and rectal formulations. Super Refined™ are particularly preferred in sensitive therapeutic areas or with unstable active pharmaceutical ingredients (APIs), thanks to our proprietary purification technology ensuring exceptionally low impurity profiles.

    Super Refined™ excipients go far beyond compendial standards. They undergo Croda Pharma’s proprietary purification process to reduce oxidative impurities such as peroxides, aldehydes, and catalyst residues—components that can cause API degradation, instability, and immunogenicity. This makes Super Refined™ excipients ideal for sensitive formulations such as injectables and biologics, where ultra-purity and batch-to-batch consistency are critical.

    Biologic drugs, such as monoclonal antibodies, are highly sensitive to oxidative stress. Even trace levels of impurities like peroxides can cause protein aggregation, loss of potency, or immunogenicity. Super Refined™ excipients help minimise these risks by eliminating those reactive impurities, making them ideal for biological formulations. 

    Injectable formulations bypass many of the body’s natural protective barriers, such as the gastrointestinal tract and first-pass metabolism. As a result, any impurities present are introduced directly into the bloodstream or tissues, where they can cause adverse reactions, inflammation, or toxicity. Using highly purified excipients like those from our Super Refined™ range helps minimise these risks, ensuring better patient safety and enhanced drug stability in parenteral formulations.

    Yes. Many of our Super Refined™ excipients include LAL bacterial endotoxin testing on their Certificates of Analysis (CoAs), supporting their use in parenteral and biologic drug formulations that require tight endotoxin control. 

    Yes. By reducing oxidative impurities that can initiate degradation pathways, Super Refined™ excipients are known to enhance API stability and extend the shelf life of drug formulations. The improved stability provided by Super Refined™ excipients may also support more flexible storage conditions, potentially reducing reliance on cold-chain requirements and enabling ambient temperature storage, depending on the formulation.

    Absolutely. Super Refined™ excipients often comply with multiple pharmacopeias (USP/NF, Ph. Eur., JP, ChP) and are listed in the FDA’s Inactive Ingredient Database (IID). This makes them a strong choice for global regulatory filings.

    Yes. While they are especially valuable in biologics due to their high purity and low impurity profile, Super Refined™ excipients also improve the performance, stability, and sensory attributes of small molecule formulations, including oral and topical products.  

    In addition to superior purity, Super Refined™ excipients come with several added benefits not typically offered with standard grades. These include: 

    • Enhanced Certificates of Analysis (CoAs) with more detailed impurity profiles, including endotoxin testing (LAL) and microbial limits for select products 
    • Nitrogen packaging for improved oxidative stability 
    • Extended pack size options, including single-use packaging 
    • Access to expertise from our technical teams to support custom requests.

    These extras provide peace of mind, accelerate regulatory submissions, and ensure consistent performance from lab-scale to launch.   

    Related resources

    • FDA IID listed products - CP22
      English: 1.3 MB
      FDA IID sheets - all administration routes in single VCN document.
      Login/Register
    • Veterinary formulation solutions
      English: 8.5 MB
      Discover our range of high purity excipients and adjuvant systems for the veterinary market.
      Login/Register
    • クローダのSuper Refined™製品シリーズ
      Japanese: 1.1 MB
      剤形の生物学的利用能、薬物送達、および薬効を高める方法をお探しですか？ Crodaの高度に精製された機能的な医薬品添加剤を用いることで、原薬の安定性を最適化し、医薬品製剤の性能を向上することができます...
      Login/Register
    • Super Refined™ pharmaceutical excipients - CP22
      English: 744.0 KB
      Super Refined™ pharmaceutical excipients
      Login/Register
    • Utilising HLB for topical formulations - CP22
      English: 793.0 KB
      Utilising HLB for topical formulations
      Login/Register

    Contact our experts today

    Croda Pharma is a world leader in pharmaceutical excipients, vaccine adjuvants and innovative lipids for human and veterinary applications. Get in touch with our experts today to get your next project started.
    Please provide an enquiry type
    Please provide your first name
    Please provide your last name
    Please provide your company name
      Please select your country
        Please select county or region
        Please provide an email address
        Please provide your message
        Please complete the recaptcha and resubmit the form.
        Form is invalid, please check again!
        Thank you for getting in touch. One of experts will be in contact soon.
        • LinkedIn
        • Youtube

        Company

        Annual Report Sustainability Report Croda.com

        Legal

        Terms and conditions Privacy policy Accessibility Cookie policy
        © 2025 Croda International Plc
        Your cookie choices

        This website uses cookies to enhance your browsing experience, and to allow us to collect information that we use to improve the site. Cookies

        Strictly necessary cookies

        Essential cookies includes the use of any cookies that are necessary in order to transmit information over an electronic communications network (and therefore make it possible for you to view the website), as well as any cookies that are strictly necessary in order to make the website function (for example, remembering information input into a webform during a browsing session, or remembering items placed in a basket by a user). This includes cookies used to comply legal obligations which apply to our website, such as our obligation to take appropriate steps to secure personal information input into the website. Personalisation – cookies used to remember your preferences (such as login details, language, font size and other display preferences) over a period of time, so you don’t have to keep re-entering them whenever you come back to the Website or browse from one page to another.

        Performance & analytics

        We use analytics cookies to collect information about your use of the website in order to understand how users interact with the website, and then make changes in order to improve the website for all users. Cookies

        Opt in to cookie